Inorbit Therapeutics is Drug Delivery in Sweden that focus on nonalcoholic steatohepatitis business. Founded in 2015. They cover business area such as developer, a chemotype, Drug-Induced Liver Injury, (DILI, development, novel therapy, nonalcoholic fatty liver disease, NAFLD, nonalcoholic steatohepatitis, NASH, patient, their health condition, drug failure.
2015
( 9 years old in 2024 )
Nonalcoholic Steatohepatitis
-
Pepparedsleden 1
431 83 Mölndal
Sweden
Private
developera chemotypeDrug-Induced Liver Injury(DILIdevelopmentnovel therapynonalcoholic fatty liver diseaseNAFLDnonalcoholic steatohepatitisNASHpatienttheir health conditiondrug failure
* We use standard office opening hours in near Inorbit Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Inorbit Therapeutics is Drug Delivery business from Sweden that founded in 2015 (9 years old in 2024), Inorbit Therapeutics business is focusing on Nonalcoholic Steatohepatitis.
Inorbit Therapeutics headquarter office and corporate office address is located in Pepparedsleden 1 431 83 Mölndal Sweden.
Inorbit Therapeutics was founded in Sweden.
In 2024, Inorbit Therapeutics is currently focus on nonalcoholic steatohepatitis sector.
Above is snippet of Google Trends for "nonalcoholic steatohepatitis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Inorbit Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
